Clinical Oncology Next Generation Sequencing Global Market Report 2023

Feb 2023| TBR1113D| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories
Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina

Clinical Oncology Next Generation Sequencing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical oncology next generation sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for clinical oncology next generation sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical oncology next generation sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Technology, By Application, By End User
Industry covered	Medical Equipment
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Thermo Fisher Scientific(Qiagen); Agilent Technologies; Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina; F. Hoffmann-La Roche; Perkin Elmer; Paradigm Diagnostics; Pacific Bioscience; Caris Life Sciences; GATC Biotech; Macrogen; Creative Biolabs; DNASTAR; Life Technologies; Exosome Diagnostics; Biomatters; Partek; Foundation Medicine; Takara Bio; BD; CLC Bio; Mogene; Knome; Genomatix Software; GnuBIO; Bio-Rad Laboratories

Scope

Markets Covered:

By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
By Application: Screening; Companion Diagnostics; Other Diagnostics
By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories

Companies Mentioned: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Clinical Oncology Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Clinical Oncology Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : Thermo Fisher Scientific(Qiagen) Financial Performance
Table 47 : Oxford Nanopore Technologies Financial Performance
Table 48 : QIAGEN Financial Performance
Table 49 : Myriad Genetics Financial Performance
Table 50 : Illumina Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Clinical Oncology Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Clinical Oncology Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : Thermo Fisher Scientific(Qiagen) Financial Performance
Figure 47 : Oxford Nanopore Technologies Financial Performance
Figure 48 : QIAGEN Financial Performance
Figure 49 : Myriad Genetics Financial Performance
Figure 50 : Illumina Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Clinical Oncology Next Generation Sequencing Global Market Report 2022

Published Date - May 2022
Report Code - TBR1113C

Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics; Other Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories
Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina; F. Hoffmann-La Roche

Clinical Oncology Next Generation Sequencing Global ...

Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth And Change To 2030

Published Date - Apr 2021
Report Code - TBR1113B

Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics; Other Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories

Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina

Clinical Oncology Next Generation Sequencing Global Market Report 2021: ...

Clinical Oncology Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change

Published Date - Nov 2020
Report Code - TBR1113A

Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics; Other Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Oraganizations; Diagnostic laboratories